Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153-163]

Nicolas Delanoy; Anne-Claire Hardy-Bessard; Eleni Efstathiou; Sylvestre Le Moulec; Umberto Basso; Alison Birtle; Alastair Thomson; Michael Krainer; Aline Guillot; Ugo De Giorgi; Ali Hasbini; Gedske Daugaard; Amit Bahl; Simon Chowdhury; Orazio Caffo; Philippe Beuzeboc; Dominique Spaeth; Jean-Christophe Eymard; Aude Fléchon; Jerome Alexandre; Carole Helissey; Mohamed Butt; Frank Priou; Eric Lechevallier; Jean-Laurent Deville; Marine Gross-Goupil; Rafael Morales; Antoine Thiery-Vuillemin; Tatiana Gavrikova; Philippe Barthélémy; Avishay Sella; Karim Fizazi; Jean-Marc Ferrero; Brigitte Laguerre; Constance Thibault; Sophie Hans; Stéphane Oudard

doi:10.1016/j.ejca.2020.05.006

Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153-163]

Eur J Cancer. 2020 Sep:137:288-289. doi: 10.1016/j.ejca.2020.05.006. Epub 2020 Jun 27.

Authors

Nicolas Delanoy¹, Anne-Claire Hardy-Bessard², Eleni Efstathiou³, Sylvestre Le Moulec⁴, Umberto Basso⁵, Alison Birtle⁶, Alastair Thomson⁷, Michael Krainer⁸, Aline Guillot⁹, Ugo De Giorgi¹⁰, Ali Hasbini¹¹, Gedske Daugaard¹², Amit Bahl¹³, Simon Chowdhury¹⁴, Orazio Caffo¹⁵, Philippe Beuzeboc¹⁶, Dominique Spaeth¹⁷, Jean-Christophe Eymard¹⁸, Aude Fléchon¹⁹, Jerome Alexandre²⁰, Carole Helissey²¹, Mohamed Butt²², Frank Priou²³, Eric Lechevallier²⁴, Jean-Laurent Deville²⁴, Marine Gross-Goupil²⁵, Rafael Morales²⁶, Antoine Thiery-Vuillemin²⁷, Tatiana Gavrikova²⁸, Philippe Barthélémy²⁹, Avishay Sella³⁰, Karim Fizazi³¹, Jean-Marc Ferrero³², Brigitte Laguerre³³, Constance Thibault¹, Sophie Hans¹, Stéphane Oudard³⁴

Affiliations

¹ European Georges Pompidou Hospital, Paris, France.
² Centre Armoricain D'Oncologie, CARIO, Plerin, France.
³ Alexandra Hospital, University of Athens, Athens, Greece; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Bergonie Institute, Bordeaux, France.
⁵ Istituto Oncologico Veneto Iov IRCCS, Padova, Italy.
⁶ Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; University Hospitals of Morecombe Bay, NHS Foundation Trust, Lancaster, UK.
⁷ Royal Cornwall Hospitals NHS Trust, Truro, UK.
⁸ Medical University of Vienna, Vienna, Austria.
⁹ Institut de Cancérologie Lucien Neuwirth, Saint Priest en Jarez, France.
¹⁰ Istituto Scientiﬁco Romagnolo per Lo Studio e La Cura Dei Tumori (IRST) IRCCS, Meldola, Italy.
¹¹ Clinique Pasteur, Brest, France.
¹² Copenhagen University Hospital, Copenhagen, Denmark.
¹³ University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
¹⁴ Guy's and St. Thomas' Hospital NHS Trust, London, UK.
¹⁵ Santa Ciara Hospital, Trento, Italy.
¹⁶ Institut Curie, Paris, France.
¹⁷ Gentilly Oncology Centre, Nancy, France.
¹⁸ Jean Godinot Institute, Reims, France.
¹⁹ Centre Léon Bérard, Lyon, France.
²⁰ Hôpital Cochin, Paris, France.
²¹ Hôpital D'Instruction des Armées, Bégin, Saint Mandé, France.
²² Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.
²³ CHD VendeeeHopital Les Oudairies, La Roche Sur Yon, France.
²⁴ La Timone Hospital, Marseille, France.
²⁵ CHU de Bordeaux, Bordeaux, France.
²⁶ University Hospital Vall D'Hebron, Barcelona, Spain.
²⁷ CHRU de Besançon, Besançon, France.
²⁸ Centre Hospitalier de Sens, Sens, France.
²⁹ Hôpital Civil, Strasbourg, France.
³⁰ Assaf Harofeh Medical Centre, Zerifin, Israel.
³¹ Gustave Roussy, University of Paris Sud, Villejuif, France.
³² Centre Antoine Lacassagne, Nice, France.
³³ Centre Eugène Marquis, Rennes, France.
³⁴ European Georges Pompidou Hospital, Paris, France. Electronic address: stephane.oudard@aphp.fr.

PMID: 32605716
DOI: 10.1016/j.ejca.2020.05.006

No abstract available

Publication types

Published Erratum